Kershner Trading Americas LLC 13D and 13G filings for NeuBase Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-27 12:49 pm Purchase | 2022-12-29 | 13G | NeuBase Therapeutics, Inc. NBSE | Kershner Trading Americas LLC | 74,861 4.460% | 74,861 (New Position) | Filing |